Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Schedule One - Ovoca Bio Plc

31 Dec 2025 08:00

RNS Number : 2768N
AIM
31 December 2025
 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

 

Ovoca Bio Plc ("Ovoca") to be renamed Talisman Metals plc on Admission ("Talisman" or the "Company")

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES):

 

17 Pembroke Street Upper

Dublin 2

D02 AT22

Ireland

 

COUNTRY OF INCORPORATION:

 

Ireland

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

 

https://www.ovocabioplc.com to be www.talismanmetalsplc.com after re-Admission

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

On 7 May 2025, Ovoca announced it had entered into a conditional Letter of Intent ("LOI") to acquire 100% of Tadeen, a UK-registered company, which indirectly owns 100% of the Licences in Morocco, prospective for Copper and Silver (the "Acquisition"), through its wholly owned subsidiary, Horizons Mines SARL.

 

Tadeen was incorporated in 2021 and since that time has sought to develop and subsequently commercialise mineral exploration and exploitation properties with strong geological potential in the promising jurisdiction of Morocco. The Company will only focus its work on 10 of the exploration permits, five comprising the Tizert Project and five making up the Argana Project, with a total combined area of 129.8km2 (together the "Exploration Permits" for the purposes of this Document). These are between 8 and 30km from the large Tizert Copper-Silver Project being developed by the Managem SA Group (Managem) the Moroccan listed Mining Group for which the Government owns a majority stake. On completion of the Transaction, various members of the senior management team of Tadeen will be integrated into the Enlarged Group. The existing Chief Executive Officer of Ovoca, Timothy McCutcheon, will serve as Chief Executive Officer of the Enlarged Group.

 

The Transaction constitutes a reverse takeover under AIM Rule 14, requiring the approval of a majority of the Shareholders voting in person or by proxy at a general meeting

 

On Admission, Talisman Metals plc will, through its wholly owned Bermudan subsidiary T Metals Limited, will own 100% of Tadeen (the acquisition target) which in turn holds 100% of Horizons Mines SARL who own the Exploration Permits.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

Number of ordinary shares of €0.02 each ("Ordinary Shares") for which Admission is being sought: 64,174,918

 

The Ordinary Shares are and will remain freely transferable and have no restrictions as to transfer placed on them.

 

The issue price: 7.7 pence (the "Issue Price").

 

No Shares are or will be held in treasury.

 

CAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

 

Capital to be raised on Admission: £1.155 million

 

Anticipated market capitalisation on Admission: approximately £4.9 million (at the Issue Price)

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

 

39.01%

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:

 

N/A

 

THE COMPANY HAS APPLIED FOR THE VOLUNTARY CARBON MARKET DESIGNATION (Y/N)

 

No

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

 

Timothy ("Tim") Rand McCutcheon - Chief Executive Officer

Leah Ellen O'Donovan - Chief Financial Officer

Jonathan George Henry - Independent Non-Executive Chair

Anastasia Levashova - Independent Non-Executive Director

Thomas ("Tom") Alan Garagan - Independent Non-Executive Director

Dr Mohammed Mouhib - Non-Executive Director

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

 

 

 

 

Name

Number of Ordinary Shares before Admission

Percentage of Existing Ordinary Shares

Number of Ordinary Shares on Admission**

Percentage of Enlarged

Share Capital

Euoclear Nominees Limited*

67,913,860

76.77%

22,637,953

35.28%

Timothy McCutheon (CEO)*

19,506,203

22.05%

6,679,613

10.41%

Picko Trading Co Limited

10,002,077

11.31%

3,334,026

5.20%

National Settlement Depository*

9,893,214

11.18%

3,297,738

5.14%

Investor Services Nominees Limited*

4,158,532

4.70%

1,386,177

2.16%

Cambrian Limited

-

-

6,252,049

9.74%

Charterhouse Trustees Limited

-

-

6,252,049

9.74%

Aya Silver & Gold Inc.

-

-

3,000,000

4.67%

Zakariae Mouhib

-

-

2,925,610

4.56%

Mohamed Baoutoul

-

-

2,925,610

4.56%

 

 

 

* All of these shares are held through Euroclear Nominees Limited

** Following a 3:1 share consolidation

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

None

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i) 31 December

(ii) 30 June 2025

(iii) As follows:

- 30 June 2026 (audited accounts for the year ended 31 December 2025)

- 30 September 2026 (unaudited interim financial statements for 6 months ended 30 June 2026)

- 30 June 2027 (audited accounts for the year ended 31 December 2026)

 

EXPECTED ADMISSION DATE:

 

28 January 2026

 

NAME AND ADDRESS OF NOMINATED ADVISER:

 

Beaumont Cornish Limited

5-10 Bolton Street

London

W1J 8BA

 

NAME AND ADDRESS OF BROKER:

 

CMC Markets UK plc

 

133 Houndsditch

London

EC3A 7BX

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

 

The AIM Admission Document, which will contain full details of the applicant and admission of its securities, will be available from the Company's website:

 

https://www.ovocabioplc.com to be www.talismanmetalsplc.com after re-Admission

 

 

THE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY

 

QCA Code

 

DATE OF NOTIFICATION:

 

31 December 2025

 

NEW/ UPDATE:

 

New

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PAAPKDBPABDKBBN
Date   Source Headline
20th Apr 20107:00 amRNSIssue of Options
31st Mar 20107:00 amRNSCorporate and Operational Update
23rd Mar 20107:00 amRNSDrilling Update
3rd Mar 20107:00 amRNSChange in Auditor
1st Mar 20109:37 amRNSStakhanovsky Mobilization
2nd Feb 20109:21 amRNSDirector/PDMR Shareholding
1st Feb 201010:28 amRNSHolding(s) in Company
21st Jan 201012:57 pmRNSIssue of Options
15th Jan 201011:53 amRNSResult of EGM
15th Jan 20107:00 amRNSIEX Notice
14th Jan 20103:50 pmRNSIssue of Equity
21st Dec 20097:00 amRNSAcquisition and Capital Reorganisation
7th Dec 20092:09 pmRNSDrilling Update
2nd Dec 200911:42 amRNSCEO Appointment and Board Changes
30th Sep 20093:41 pmRNSInterim Results
24th Jul 20092:42 pmRNSResults of AGM and Board Changes
14th Jul 20092:14 pmRNSOperational Update
26th Jun 20092:52 pmRNSNotice of AGM and Annual Reports & Accounts
16th Jun 20091:28 pmRNSAppointment of Investment Manager
13th May 200911:56 amRNSOperational Update
19th Mar 20094:10 pmRNSDisposal
23rd Jan 20093:08 pmRNSDisposal Completion
19th Jan 20095:22 pmRNSBoard Appointment
19th Jan 20095:18 pmRNSResult of EGM & AGM
5th Jan 20092:50 pmRNSBoard Change
29th Dec 20085:08 pmRNSReplacement - Notice of AGM
29th Dec 20084:14 pmRNSNotice of AGM
19th Dec 20084:02 pmRNSProposed Disposal
19th Nov 20087:21 amRNSPolymetal Acquires Goltsovoye Deposit
19th Nov 20087:00 amRNSProposed Disposal
29th Oct 200812:12 pmRNSBoard Change
20th Oct 20087:00 amRNSQuarterly Letter
15th Sep 200811:49 amRNSIEX Notice
9th Sep 20082:19 pmRNSEquity Placing
2nd Sep 200811:48 amRNSInterim Results
29th Jul 200811:07 amRNSProject Financing
16th Jul 20087:00 amRNSOperational Update
9th Jul 20087:00 amRNSOperational Update
1st Jul 20087:00 amRNSDocument Availability
19th Jun 200810:38 amRNSGoltsovoye Public Hearings
29th May 20082:09 pmRNSLicence Amendment
20th May 200811:01 amRNSHolding(s) in Company
24th Apr 20084:06 pmRNSIssue of Equity
3rd Mar 20087:01 amRNSLicence Extension
18th Feb 200810:22 amRNSDrilling Results
14th Feb 20084:12 pmRNSBoard Change
15th Jan 200811:04 amRNSBankable Feasibility Study
28th Dec 20074:13 pmRNSOperational Update
7th Dec 20077:00 amRNSIEX Notice
3rd Dec 20075:04 pmRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.